González VHJ, Concepción RMT

Language: Spanish
References: 12
Page: 349-351
PDF size: 649.18 Kb.

ABSTRACT

Objective: to implement an educative intervention strategy in the Family Doctor Office 66 in “Hermanos Cruz” polyclinic to rather the knowledge on main risk factors for the cervical uterine cancer in fertility age women.
Method: a study of educative intervention, coast experimental, prospective and longitudinal was carried out. The demography data were analized by percentage method and to determine the efficacy of the intervention program the responses for each questionaire were computed, with the parametric test of proportion comparison for two pair population the results were interpretated and analized by Mc Nemar statistical test.
Results: the sample of 94 patients, predominated 30-39 years, high school level, presence of risk factor with 59 patients and the best results were reached to the knowledge of risk factors associated with the apparition of cervical uterine cancer with 86 patients.
Conclusions: the effectiveness of the educative intervention is demonstrated.

REFERENCES

1. Organización panamericana de la salud manual de normas y procedimientos pa-ra el control del cáncer de cuello uterino. Washington, D: OPS, 2010; 1-8

2. Ricardo Rigor O, Pérez Carballés F, Perea Corral J, Fernández Sacasas J, Fer-nández Mirabal J. Medicina general integral. La Habana: Editorial Pueblo y edu-cación 2009. 2009; t 4 21-32

3. Schneider A, Koutsky LA, Natural history and epidemiological feature of genital HPV infection In: Muñoz M, Bosch F, Shah KV, Meheus A, editors, The epidemi-ology of human papilomavirus and cervical cáncer, Lyon; International Agency for Research on Cancer; 2013.

4. Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papilomavirus in cervical cáncer a worldwide perspective. J Natl Cancer Inst 2012;87:796

5. Gustafsson L, Pontén J, Zack M, Adami HOIO. Internation incidence rates of inva-sive cervical cáncer after introduction of cytological screening. Cancer Causes Control 1997; 8(5): 755-763.

6. Parkin DM, Bray F. The burdem of HPV-related cáncer. Vaccine 2006;24(Supple3):S11-S25

7. Walboomers JMM, Jacobs MV, Manos MM, Kummer JA, Shah KV, et al. Human Papilomavirus is a necessary cause of invasive cervical cáncer worldwide. J Pathol 1999;189(1):12-19

8. De Sanjose S, Quint WGV, Alemany L, Geraets DT, Klaustermeier JE, LLoveras B, et al. Retrospective International Survey and HPV Time Trends Study Group. Human Papilomavirus genotupe attribution in invasive cervical cáncer; a retrospec-tive cross-sectional worldwide study, Lancet Oncol 2012; 11(11): 1048-1056.

9. Muñoz N. Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. In-ternational Ageny for Research on Cancer Multicenter Cervical Cancer Study Group, Epidemiologic Classification of Human Papilomavirus Types Associated with Cervical Cancer, N Engl J Med 2003,348(6). 518-527.

10. Saslow D, Solomon D, Lawson HW,Hillackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathol-ogy, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cáncer. Ca Cancer J Clin 2012; 62(3): 147-172.

11. Wright TC Jr, Schiffman M. Adding a test for Human Papilomavirus DNA to cervi-cal-cancer screening. N Engl J Med 2013; 348(6): 489-490.

12. Bosh LP. Uses of date to plan cáncer prevention and control programmes, Public Health Rew, 2001; 105(4):354-60.2.Parkin Dm. Global cáncer statistics in the year 2000. Lancet Oncol. 2013 Sep; 2(9): 533-43.